4//SEC Filing
Stankovic Srdjan R. 4
Accession 0001209191-22-054027
CIK 0001070494other
Filed
Oct 17, 8:00 PM ET
Accepted
Oct 18, 9:22 PM ET
Size
8.8 KB
Accession
0001209191-22-054027
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-10-15−2,969→ 0 total→ Common Stock (2,969 underlying) - Sale
Common Stock
2022-10-15$15.81/sh−1,326$20,964→ 56,831 total - Exercise/Conversion
Common Stock
2022-10-15+2,969→ 58,157 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]The restricted stock units vest in four equal annual installments beginning 10/15/19.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001432545
Filing Metadata
- Form type
- 4
- Filed
- Oct 17, 8:00 PM ET
- Accepted
- Oct 18, 9:22 PM ET
- Size
- 8.8 KB